• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录因子表达与无功能垂体腺瘤生长模式之间的关联

Association between transcription factors expression and growth patterns of nonfunctioning pituitary adenomas.

作者信息

Xu Jiakun, Zhang Shaolin, Su Weijie, Yang Jia, Yang Lixuan, Li Xixi

机构信息

Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.

Department of Neurosurgery, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China.

出版信息

Sci Rep. 2025 Jan 2;15(1):601. doi: 10.1038/s41598-024-84261-y.

DOI:10.1038/s41598-024-84261-y
PMID:39747515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11696072/
Abstract

Transcription factors (TFs), including steroidogenic factor-1 (SF-1), T-box transcription factor (TPIT) and pituitary transcription factor-1 (PIT-1), play a pivotal role in the cytodifferentiation of adenohypophysis. However, the impact of TFs on the growth patterns of nonfunctioning pituitary adenomas (NFPAs) remains unclear. This study aims to investigate the correlation between the expression of TFs and NFPAs growth patterns. Preoperative MRI in 171 patients who underwent surgery for nonfunctioning pituitary macroadenomas were analyzed to determine tumor growth patterns. Immunohistochemical staining for transcription factors PIT-1, TPIT, and SF-1 was done on all samples. Extrasellar growth was divided into three principal directions: infrasellar, suprasellar and lateral cavernous sinus invasion (CSI). Suprasellar extension was defined as tumor extension superior to the tuberculum sellae-dorsum sellae line, inferior extension as invasion through the sellar floor into the sphenoid sinus or clivus and CSI as Knosp grading score of 3 ~ 4. Statistical analysis to compare the groups was conducted using the Fisher's exact test and t-test. TPIT-expressing tumors were more likely to exhibit combined infrasellar extension (55.17 vs 17.70%, p < 0.0001), as well as isolated infrasellar extension (18.97 vs 0%, p < 0.0001) compared to SF-1-expressing tumors. Conversely, SF-1-expressing tumors were more likely to exhibit combined suprasellar extension (92.92 vs 77.59%, p = 0.0061), as well as isolated suprasellar extension (75.22 vs 41.38%, p < 0.0001). TPIT-expressing tumors had a significantly higher CSI invasion (55.17 vs 35.40%, p = 0.0148). The mean maximal tumor diameter in TPIT and SF-1 macroadenomas was similar (28 vs 26 mm, p = 0.1213). The expression of TFs affects the extrasellar growth pattern of NFPAs. TPIT tumors exhibit a higher propensity for bone invasion and CSI, while SF-1 tumors tend to extend into the suprasellar region. Isolated infrasellar extension is specific to TPIT tumors and can serve as a radiologic sign to distinguish between TPIT tumors and SF-1 tumors.

摘要

转录因子(TFs),包括类固醇生成因子-1(SF-1)、T盒转录因子(TPIT)和垂体转录因子-1(PIT-1),在腺垂体的细胞分化中起关键作用。然而,TFs对无功能垂体腺瘤(NFPAs)生长模式的影响仍不清楚。本研究旨在探讨TFs表达与NFPAs生长模式之间的相关性。分析了171例接受无功能垂体大腺瘤手术患者的术前MRI,以确定肿瘤生长模式。对所有样本进行转录因子PIT-1、TPIT和SF-1的免疫组织化学染色。鞍外生长分为三个主要方向:鞍下、鞍上和外侧海绵窦侵袭(CSI)。鞍上延伸定义为肿瘤延伸至鞍结节-鞍背线以上,向下延伸定义为通过鞍底侵入蝶窦或斜坡,CSI定义为Knosp分级评分3至4级。使用Fisher精确检验和t检验进行组间比较的统计分析。与表达SF-1的肿瘤相比,表达TPIT的肿瘤更易出现合并鞍下延伸(55.17%对17.70%,p<0.0001)以及孤立性鞍下延伸(18.97%对0%,p<0.0001)。相反,表达SF-1的肿瘤更易出现合并鞍上延伸(92.92%对77.59%,p=0.0061)以及孤立性鞍上延伸(75.22%对41.38%,p<0.0001)。表达TPIT的肿瘤有显著更高的CSI侵袭率(55.17%对35.40%,p=0.0148)。TPIT和SF-1大腺瘤的平均最大肿瘤直径相似(28mm对26mm,p=0.1213)。TFs的表达影响NFPAs的鞍外生长模式。TPIT肿瘤表现出更高的骨侵袭和CSI倾向,而SF-1肿瘤倾向于延伸至鞍上区域。孤立性鞍下延伸是TPIT肿瘤所特有的,可作为区分TPIT肿瘤和SF-1肿瘤的影像学标志。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c847/11696072/ff4ed09c0a5d/41598_2024_84261_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c847/11696072/6fc5295d6741/41598_2024_84261_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c847/11696072/1351a13e34a8/41598_2024_84261_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c847/11696072/ff4ed09c0a5d/41598_2024_84261_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c847/11696072/6fc5295d6741/41598_2024_84261_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c847/11696072/1351a13e34a8/41598_2024_84261_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c847/11696072/ff4ed09c0a5d/41598_2024_84261_Fig2_HTML.jpg

相似文献

1
Association between transcription factors expression and growth patterns of nonfunctioning pituitary adenomas.转录因子表达与无功能垂体腺瘤生长模式之间的关联
Sci Rep. 2025 Jan 2;15(1):601. doi: 10.1038/s41598-024-84261-y.
2
Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas.生长激素型垂体腺瘤与无功能垂体腺瘤相比,具有明显的鞍外延伸模式。
Pituitary. 2022 Jun;25(3):480-485. doi: 10.1007/s11102-022-01217-z. Epub 2022 Mar 25.
3
Multiple microcysts and clivus invasion diagnose T-box pituitary transcription factor 19 lineage adenomas in non-functioning pituitary adenomas.多个微囊肿和斜坡侵犯可诊断无功能垂体腺瘤中的T盒垂体转录因子19谱系腺瘤。
Acta Radiol. 2025 Apr;66(4):441-449. doi: 10.1177/02841851251313555. Epub 2025 Jan 27.
4
The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.转录因子在临床无功能垂体腺瘤准确诊断中的互补作用
Endocr Pathol. 2015 Dec;26(4):349-55. doi: 10.1007/s12022-015-9398-z.
5
Cytodifferentiation of pituitary tumors influences pathogenesis and cavernous sinus invasion.垂体瘤的细胞分化影响其发病机制和海绵窦侵袭。
J Neurosurg. 2023 Apr 28;139(5):1216-1224. doi: 10.3171/2023.3.JNS221949. Print 2023 Nov 1.
6
Patterns of extrasellar extension in growth hormone-secreting and nonfunctional pituitary macroadenomas.生长激素分泌型和无功能垂体大腺瘤的鞍外扩展模式。
Neurosurg Focus. 2010 Oct;29(4):E4. doi: 10.3171/2010.7.FOCUS10155.
7
Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.根据世界卫生组织 2017 年标准分类的垂体腺瘤中激素免疫染色的数字分析及其与术前实验室检查结果的相关性。
Neurosurg Focus. 2020 Jun;48(6):E12. doi: 10.3171/2020.3.FOCUS2039.
8
Clinicopathological correlates of extrasellar growth patterns in pituitary adenomas.垂体腺瘤鞍外生长模式的临床病理相关性
J Clin Neurosci. 2015 Jul;22(7):1173-7. doi: 10.1016/j.jocn.2015.01.029. Epub 2015 May 12.
9
The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.T 盒转录因子在垂体腺瘤诊断算法中的作用。
Arch Pathol Lab Med. 2021 May 1;145(5):592-598. doi: 10.5858/arpa.2020-0091-OA.
10
Silent Corticotroph Adenomas Demonstrate Predilection for Sphenoid Sinus, Cavernous Sinus, and Clival Invasion Compared with Other Subtypes.与其他亚型相比,沉默型促肾上腺皮质激素腺瘤更倾向于侵犯蝶窦、海绵窦和斜坡。
World Neurosurg. 2024 Nov;191:e41-e47. doi: 10.1016/j.wneu.2024.08.027. Epub 2024 Aug 21.

本文引用的文献

1
Morphological Classification of Pituitary Tumors With Suprasellar Extension.伴有鞍上扩展的垂体肿瘤的形态学分类
Neurosurgery. 2023 Dec 4. doi: 10.1227/neu.0000000000002786.
2
The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis.无功能促肾上腺皮质激素瘤的临床病理特征及预后:一项更新的系统评价和荟萃分析
Endocrine. 2023 Dec;82(3):527-535. doi: 10.1007/s12020-023-03449-w. Epub 2023 Jul 18.
3
Cytodifferentiation of pituitary tumors influences pathogenesis and cavernous sinus invasion.
垂体瘤的细胞分化影响其发病机制和海绵窦侵袭。
J Neurosurg. 2023 Apr 28;139(5):1216-1224. doi: 10.3171/2023.3.JNS221949. Print 2023 Nov 1.
4
Radiomics model and clinical scale for the preoperative diagnosis of silent corticotroph adenomas.基于影像组学模型和临床量表的术前诊断无功能性促肾上腺皮质腺瘤
J Endocrinol Invest. 2023 Sep;46(9):1843-1854. doi: 10.1007/s40618-023-02042-2. Epub 2023 Apr 5.
5
Subclassification of Knosp Grade 4 Pituitary Adenoma: Bringing Insights Into the Significance of Tumor Growth Pathways.Knosp 分级 4 级垂体腺瘤的再分类:深入探讨肿瘤生长途径的意义。
Neurosurgery. 2023 Jan 1;92(1):213-222. doi: 10.1227/neu.0000000000002197. Epub 2022 Nov 4.
6
Clinical Biology of the Pituitary Adenoma.垂体腺瘤的临床生物学。
Endocr Rev. 2022 Nov 25;43(6):1003-1037. doi: 10.1210/endrev/bnac010.
7
Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas.生长激素型垂体腺瘤与无功能垂体腺瘤相比,具有明显的鞍外延伸模式。
Pituitary. 2022 Jun;25(3):480-485. doi: 10.1007/s11102-022-01217-z. Epub 2022 Mar 25.
8
Overview of the 2022 WHO Classification of Pituitary Tumors.《2022 年世卫组织垂体肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):6-26. doi: 10.1007/s12022-022-09703-7. Epub 2022 Mar 15.
9
Clinical Course and Unique Features of Silent Corticotroph Adenomas.无功能性垂体腺瘤的临床病程及独特特征
World Neurosurg. 2022 May;161:e274-e281. doi: 10.1016/j.wneu.2022.01.119. Epub 2022 Feb 4.
10
Outcomes and surgical nuances in management of giant pituitary adenomas: a review of 108 cases in the endoscopic era.巨大垂体腺瘤治疗的结果与手术细节:内镜时代108例病例回顾
J Neurosurg. 2022 Jan 21;137(3):635-646. doi: 10.3171/2021.10.JNS21659. Print 2022 Sep 1.